Christine Ring
Compliance Officer chez NURIX THERAPEUTICS, INC.
Fortune : 291 619 $ au 31/03/2024
Profil
Christine Ring is currently the Chairman at BIOMILQ, Inc. and the Secretary, Chief Legal & Compliance Officer at Nurix Therapeutics, Inc. She previously worked as a Principal at Kosan Biosciences, Inc. and Sunesis Pharmaceuticals, Inc. She also held the position of Senior VP & Chief Intellectual Property Counsel at Amyris, Inc. for a brief period in 2014.
Additionally, she worked as a Principal at Pillsbury Madison & Sutro LLP and as the Senior Vice President-Legal at Dermira, Inc. Dr. Ring holds a graduate degree from Hastings College, an undergraduate degree from the University of California, Berkeley, and a doctorate degree from the University of California, San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC.
0,04% | 30/04/2024 | 19 838 ( 0,04% ) | 291 619 $ | 31/03/2024 |
Postes actifs de Christine Ring
| Sociétés | Poste | Début |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Compliance Officer | 01/10/2023 |
BIOMILQ, Inc.
 BIOMILQ, Inc. Miscellaneous Commercial ServicesCommercial Services BIOMILQ operates mother-cultured infant breast milk company. The company was founded by Leila Strickland and Michelle Egger and is headquartered in Durham, NC. | Chairman | 01/03/2023 |
Anciens postes connus de Christine Ring
| Sociétés | Poste | Fin |
|---|---|---|
| DERMIRA, INC. | General Counsel | - |
| Pillsbury Madison & Sutro LLP | Corporate Officer/Principal | - |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| AMYRIS, INC. | Corporate Officer/Principal | - |
Formation de Christine Ring
| Hastings College | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMYRIS, INC. | Process Industries |
| NURIX THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
| Pillsbury Madison & Sutro LLP | Commercial Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
BIOMILQ, Inc.
BIOMILQ, Inc. Miscellaneous Commercial ServicesCommercial Services BIOMILQ operates mother-cultured infant breast milk company. The company was founded by Leila Strickland and Michelle Egger and is headquartered in Durham, NC. | Commercial Services |
